Literature DB >> 9809871

Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury.

W Tavares de Lima1, A A Steil, M Russo, N Starobinas, C F Teixeira, S Jancar.   

Abstract

We investigated the contribution of eicosanoids, platelet-activating factor, tumor necrosis factor and nitric oxide to the neutrophil influx and development of pulmonary haemorrhagic lesions following immune-complex-induced pneumonitis in rats and possible interactions between these mediators. Increased levels of leukotriene B4 and tumor necrosis factor, measured by enzyme immunoassay and L-929 cytotoxicity assay, were found in the bronchoalveolar lavage 1 and 4 h after induction of the reaction, respectively, and their release was dependent on the previous generation of platelet activating factor. Antagonism of leukotriene B4 receptors by RO-0254094 (2-[(5-carboxypentyl])oxy]-6-[6-[3,4-dihydro-4-oxo-8-propyl-2H-1-benzopy ran-7-yl)oxy]hexyl] benzenepropanoic acid), inhibition of nitric oxide synthesis by L-NAME (Nw-nitro-L-arginine methyl ester) and antagonism of PAF-receptors by WEB-2170 (5-(2-chlorphenyl)-3-4-dihydro-10-methyl-3-((4-morpholinyl)carbony l)-2 H,7H-cyclopenta (4,5)thieno(3,2-f)(1,2,4)-triazolo-4,3,a)91,4)diazepine), significantly inhibited the intensity of haemorrhage, evaluated by the increased levels of extravascular hemoglobin in homogenates of lung tissues. Little evidence support the role of tumor necrosis factor in these lesions. The infiltration of neutrophils, evaluated by measuring myeloperoxidase in homogenates of lungs, was reduced by compounds L-663,536 (3-[1-(4 chlorobenzyl)-3-t-butyl thio-5-isopropylindol-2-yl]-2-2-dimethylpropanoic acid), WEB-2170 and L-NAME. These results indicate that neutrophil infiltration and haemorrhagic lesions in immune-complex-induced lung inflammation are mediated by platelet activating factor, leukotriene B4 and nitric oxide and point out to interesting interactions between these mediators.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809871     DOI: 10.1016/s0014-2999(98)00594-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.

Authors:  A C Soares; V S Pinho; D G Souza; T Shimizu; S Ishii; J R Nicoli; M M Teixeira
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Authors:  C F P Teixeira; S Jancar; W T Lima; P D'Orléans-Juste; P Sirois
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

3.  Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.

Authors:  D G Souza; D C Cara; G D Cassali; S F Coutinho; M R Silveira; S P Andrade; S P Poole; M M Teixeira
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-alpha levels in rat diaphragm muscle.

Authors:  F Aimbire; R A B Lopes-Martins; H C Castro-Faria-Neto; R Albertini; M C Chavantes; M T T Pacheco; P S L M Leonardo; V V Iversen; J M Bjordal
Journal:  Lasers Med Sci       Date:  2006-10-11       Impact factor: 3.161

5.  Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.

Authors:  Barry B Rubin; Gregory P Downey; Adeline Koh; Norbert Degousee; Farideh Ghomashchi; Laxman Nallan; Eva Stefanski; Denis W Harkin; Chunxiang Sun; Brian P Smart; Thomas F Lindsay; Vera Cherepanov; Eric Vachon; David Kelvin; Martin Sadilek; Glenn E Brown; Michael B Yaffe; Jonathan Plumb; Sergio Grinstein; Michael Glogauer; Michael H Gelb
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

6.  Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1beta levels in airway and lung from rat subjected to LPS-induced inflammation.

Authors:  F Aimbire; A P Ligeiro de Oliveira; R Albertini; J C Corrêa; C B Ladeira de Campos; J P Lyon; J A Silva; M S Costa
Journal:  Inflammation       Date:  2008-04-18       Impact factor: 4.092

7.  Regulatory effects of iNOS on acute lung inflammatory responses in mice.

Authors:  Cecilia L Speyer; Thomas A Neff; Roscoe L Warner; Ren-Feng Guo; J Vidya Sarma; Niels C Riedemann; Megan E Murphy; Hedwig S Murphy; Peter A Ward
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injury.

Authors:  Pietro Roversi; Bernhard Ryffel; Dieudonnée Togbe; Isabelle Maillet; Mauro Teixeira; Nurfilza Ahmat; Guido C Paesen; Olga Lissina; Wilhelm Boland; Kerstin Ploss; Joseph J E Caesar; Susanne Leonhartsberger; Susan M Lea; Miles A Nunn
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.